Materials & Resources » Chemicals | Cambrex Corp.

Cambrex Corp. | Mutual Funds

Mutual Funds that own Cambrex Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Small Cap ETF
1,808,683
5.44%
513
0.26%
09/06/2018
Vanguard Small Cap Index Fund
829,443
2.49%
11,095
0.06%
07/31/2018
Vanguard Total Stock Market Index Fund
818,665
2.46%
1,012
0.01%
07/31/2018
Columbia Acorn Fund
713,340
2.15%
0
0.89%
03/29/2018
iShares Russell 2000 ETF
696,227
2.09%
-372
0.1%
09/06/2018
ClearBridge Small Cap Growth Fund
655,278
1.97%
0
1.21%
01/31/2018
Mackenzie US Mid Cap Growth Class
634,844
1.91%
6,698
2.2%
06/30/2018
William Blair Small Mid Cap Growth Fund
507,126
1.53%
79,952
1.27%
06/30/2018
Vanguard Small Cap Growth Index Fund
472,709
1.42%
6,384
0.12%
07/31/2018
Vanguard Extended Market Index Fund
436,290
1.31%
6,100
0.04%
07/31/2018

About Cambrex

View Profile
Address
One Meadowlands Plaza
East Rutherford New Jersey 07073
United States
Employees -
Website http://www.cambrex.com
Updated 07/08/2019
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates.